| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 12/30/2008 | CA2312098C A process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs |
| 12/30/2008 | CA2285389C Use of cytoskeletal inhibitors for the prevention of restenosis |
| 12/30/2008 | CA2245587C Novel benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists |
| 12/30/2008 | CA2226256C New thrombin inhibitors, their preparation and use |
| 12/25/2008 | US20080319165 Nucleic acid molecule comprising a nucleic acid sequence coding for a chemokine, a neuropeptide precursor, or at least one neuropeptide |
| 12/25/2008 | US20080319046 Substituted sulfonamide-indoles |
| 12/25/2008 | US20080319021 Inhibition Of Phosphoinositide 3-Kinase Beta |
| 12/25/2008 | US20080318944 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 12/25/2008 | US20080318850 Glycopegylated Factor Ix |
| 12/25/2008 | US20080318841 Method For Preparing a Factor H Concentrate and the Use Thereof in the Form of a Drug |
| 12/25/2008 | US20080317871 Use of Hydrochloric Acid For the Manufacture of a Medicament For the Treatment of Hypertension |
| 12/25/2008 | US20080317834 Compounds and methods for modulating cerebral amyloid angiopathy |
| 12/25/2008 | US20080317774 Composition For Inhibiting Thrombosis |
| 12/25/2008 | US20080317745 Methods of diagnosing, treating, or preventing plasma cell disorders |
| 12/25/2008 | US20080317735 Pharmaceutical preparation with RNA as hemostasis cofactor |
| 12/25/2008 | US20080317723 Lymphatic endothelial cells materials and methods |
| 12/24/2008 | WO2008157593A2 Protein c for use in maintaining hemostasis |
| 12/24/2008 | WO2008156208A1 5-phenyl-3-pyridazinone derivative |
| 12/24/2008 | WO2008155509A2 Modified human factor vii/viia and pharmaceutical composition containing same |
| 12/24/2008 | WO2008155069A2 Substituted oxazolidinones and use thereof |
| 12/24/2008 | WO2008155034A1 Substituted oxazolidinones and the use thereof |
| 12/24/2008 | WO2008155033A1 Substituted (oxazolidinon-5-yl-methyl) -2-thiophene-carboxamides and use thereof in the field of blood coagulation |
| 12/24/2008 | WO2008155032A1 Substituted (oxazolidinon-5-yl-methyl) -2-thiophene-carboxamides and use thereof in the field of blood coagulation |
| 12/24/2008 | WO2008154795A1 Use of sanchiosides for treating septicemia |
| 12/24/2008 | WO2008154794A1 The use of an extract of salvia miltiorrhiza for manufacture of a medicament for treatment of septicemia |
| 12/24/2008 | WO2008115999A8 Biaryl and biheteroaryl compounds useful in treating iron disorders |
| 12/24/2008 | WO2008088820A3 Glutamate receptor antagonists and methods of use |
| 12/24/2008 | WO2008017670A8 Pyrrolo [3, 2 -d] pyrimidines as dpp-iv inhibitors for the treatment of diabetes mellitus |
| 12/24/2008 | EP2006380A1 Agonistic antibody directed against human thrombopoietin receptor |
| 12/24/2008 | EP2005952A1 Tamsulosin-containing percutaneous absorption type preparation |
| 12/24/2008 | EP2005948A2 Perfluorocarbon gas transferring emulsion for medico-biological use, the composition and the production method thereof a medicinal agent |
| 12/24/2008 | EP2004214A1 Methods for local treatment with factor vii |
| 12/24/2008 | DE69922977C5 Neue Kristallmodifikation von Torasemid New crystal modification of torasemide |
| 12/24/2008 | DE102007028407A1 Substituierte Oxazolidinone und ihre Verwendung Substituted oxazolidinones and their use |
| 12/24/2008 | DE102007028406A1 Substituierte Oxazolidinone und ihre Verwendung Substituted oxazolidinones and their use |
| 12/24/2008 | DE102007028320A1 Substituierte Oxazolidinone und ihre Verwendung Substituted oxazolidinones and their use |
| 12/24/2008 | DE102007028319A1 Substituierte Oxazolidinone und ihre Verwendung Substituted oxazolidinones and their use |
| 12/24/2008 | CN101328227A Sea lettuce polysaccharide, preparation and use thereof |
| 12/24/2008 | CN101328226A Low molecular rhamnosan sulfate, preparation and use thereof |
| 12/24/2008 | CN101328225A Sulfuric acid rhamnosan, preparation and use thereof |
| 12/24/2008 | CN101328213A G-CSF conjugates |
| 12/24/2008 | CN101327284A Anticoagulant medicine made from Chinese medicine |
| 12/24/2008 | CN101327249A Use of Radix salvia miltiorrhiza extract for treating septicemia |
| 12/24/2008 | CN101327236A Use of pseudo-ginseng saponin component for treating septicemia |
| 12/24/2008 | CN101327235A Use of pseudo-ginseng saponins for treating septicemia |
| 12/24/2008 | CN101327232A Method for preparing Hippophae rhamnoides flavones separated and purified by polyamide and uses thereof |
| 12/24/2008 | CN101327221A Medical use of Ophiopogon root saponin D as tissue factor pathway inhibitor |
| 12/24/2008 | CN101327214A Medicine use of isoquinoline alkaloids as tissue factor inhibitor |
| 12/24/2008 | CN101327202A Vitamin K1 lyophilized powder for injection and preparation method |
| 12/24/2008 | CN101327200A Glycerol fruit sugar injection and preparation method thereof |
| 12/24/2008 | CN100445390C High activity, low antigen glucokinase derivant and preparation method |
| 12/24/2008 | CN100445389C Low antigen recombination glucokinase mutant and its preparation method |
| 12/24/2008 | CN100445380C Therapeutically useful synthetic oligonucleotides |
| 12/24/2008 | CN100444839C Treatment of chemokine mediated diseases |
| 12/24/2008 | CA2692178A1 Substituted oxazolidinones and use thereof |
| 12/24/2008 | CA2692172A1 Substituted oxazolidinones and the use thereof |
| 12/24/2008 | CA2692166A1 Substituted (oxazolidinon-5-yl-methyl)-2-thiophene-carboxamides and use thereof in the field of blood coagulation |
| 12/24/2008 | CA2691243A1 Thrombin inhibitor |
| 12/24/2008 | CA2691110A1 Modified human factor vii/viia and pharmaceutical composition containing same |
| 12/24/2008 | CA2691095A1 Hemostatic agents |
| 12/24/2008 | CA2687968A1 Stabilized thrombin compositions |
| 12/23/2008 | US7468361 For therapy of skin conditions selected from the group consisting of dermatitis, eczema, keratosis, lack of skin firmness, wrinkles, lack of dermal hydration and insufficient sebum secretion |
| 12/23/2008 | US7468359 Compositions comprising oxophosphonate-based metalloproteinase inhibitors |
| 12/23/2008 | US7468276 Bloodless mammalian placenta for use in generating multipotent stem cells |
| 12/18/2008 | WO2008153027A1 Pyrroloquinoline derivative and use thereof |
| 12/18/2008 | WO2008152888A1 Method of purifying microorganisms and method of detecting microorganisms |
| 12/18/2008 | WO2008151817A1 Use of vwf stabilized fviii preparations and of vwf preparations without fviii for extravascular administration in the therapy and prophylactic treatment of bleeding disorders |
| 12/18/2008 | WO2008151390A1 Differentiation of human embryonic stem cells |
| 12/18/2008 | US20080312308 Substituted acetic acid derivatives |
| 12/18/2008 | US20080312290 Oil Based Suspension Concentrates |
| 12/18/2008 | US20080312257 Triazolopyrimidine derivatives as ADP P2Y12 receptor antagonists |
| 12/18/2008 | US20080312208 Pyridine Analogues |
| 12/18/2008 | US20080312179 High level expression of recombinant human erythropoietin having a modified 5'-UTR |
| 12/18/2008 | US20080312170 Fibrinolysin of Agkistrodon Acutus Venom and its Usage |
| 12/18/2008 | US20080312138 Erythropoietin complementation or replacement |
| 12/18/2008 | US20080312127 Host Cell Comprising a Vector for Production of Proteins Requiring Gamma-Carboxylation |
| 12/18/2008 | US20080311599 Antibodies against caspase-8, their preparation and use |
| 12/18/2008 | US20080311118 Vascular endothelial cell growth factor antagonists and uses thereof |
| 12/18/2008 | US20080311105 Reversibly Inactivated Acidified Plasmin |
| 12/18/2008 | DE102007027800A1 Substituierte bicyclische Heteroaryl-Verbindungen und ihre Verwendung Substituted bicyclic heteroaryl compounds and their use |
| 12/18/2008 | DE102007027799A1 Substituierte Furopyrimidine und ihre Verwendung Substituted Furopyrimidine and their use |
| 12/18/2008 | CA2690218A1 Use of vwf stabilized fviii preparations and of vwf preparations without fviii for extravascular administration in the therapy and prophylactic treatment of bleeding disorders |
| 12/18/2008 | CA2688265A1 Selective cell therapy for the treatment of renal failure |
| 12/17/2008 | EP2003136A1 Process for producing high-purity prasugrel and acid addition salt thereof |
| 12/17/2008 | EP2001555A1 Use of strobilurins for treating malfunctions of the iron metabolism |
| 12/17/2008 | EP2001504A2 Use of thrombin mutants to inhibit the anticoagulation effect of thrombin inhibitors |
| 12/17/2008 | EP2001490A1 Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement |
| 12/17/2008 | EP2001471A1 Use of combination preparations containing thrombin receptor antagonists for treating cardiovascular disorders |
| 12/17/2008 | EP2001466A2 Formulations and methods for vascular permeability-related diseases or conditions |
| 12/17/2008 | EP1684744A4 Pyrrolidine and piperidine derivatives as factor xa inhibitors |
| 12/17/2008 | EP1572889B1 Nucleic acid and amino acid sequences encoding high-level expressor factor viii polypeptides and methods of use |
| 12/17/2008 | EP1536778B1 Proteins binding to cross-beta structure comprising amyloid and methods for modulation of the cross-beta structure, its formation and its associated toxicity |
| 12/17/2008 | EP1377284B1 Controlled release arginine formulations |
| 12/17/2008 | EP1077943B1 Heterocyclic inhibitors of p38 |
| 12/17/2008 | CN101325957A Microangiopathy treatment and prevention |
| 12/17/2008 | CN101322824A Oral liquid for refreshing oneself, promoting digestion and enriching blood |
| 12/17/2008 | CN101322817A Compound flavescent sophora root sustained-release dropping pill and preparation thereof |
| 12/17/2008 | CN101322812A Chinese medicine for treating epistaxis around menstrual period |
| 12/17/2008 | CN101322811A Chinese medicine for treating epistaxis |
| 12/17/2008 | CN101322803A Hemostatic and anti-inflammation powder |